Mounjafei active ingredient tirzepatide is approved for weight loss. It is used for type 2 diabetes in adults to lower blood sugar levels (blood glucose) and A1C levels. Mounjafei is a once-weekly injection that should be used with diet and exercise. Clinical trials for a 15 mg dose of mounjafei (tirzepatide) for weight loss showed patients lost a mean of 20.9% of their body weight compared to 3.1% for placebo over 72 weeks.
Keifei - Tirzepatide - Mounjafei - 10mg Pen
Mounjafei works to lower blood sugar by helping the pancreas make more insulin, lowering the amount of sugar your liver makes, and slowing the rate food passes through your body, making you feel full longer. It does this by activating the two receptors, GIP and GLP-1, which are natural incretin hormones that help regulate blood sugar levels.
